Show simple item record

 
dc.contributorDepartament de Salut
dc.date.accessioned2018-11-16T12:36:30Z
dc.date.available2018-11-16T12:36:30Z
dc.date.issued2018-04-04
dc.identifier.citationPaclitaxel unit a l'albúmina: tractament de primera línia del càncer de pàncrees metastàtic. Barcelona: Servei Català de la Salut; 2018.
dc.identifier.urihttp://hdl.handle.net/11351/3660
dc.descriptionPaclitaxel; Adenocarcinoma; Palliative treatment
dc.description.abstractPancreatic cancer is one of the most aggressive and with less healing percentage. In Europe, pancreatic cancer is the seventh most common cancer, and represents 2.9% of cancer in men and 3.2% in women. It is also the fifth most important cause of death for cancer in Europe. The diagnosis is rare before age 45. In 80% of cases it occurs in ages between 60 and 80 years. It has a high mortality rate, mainly due to the fact that most patients (<50%) have a metastatic disease diagnosis, with a median survival of only 7-11 months. 30% -40% of patients have localized but non-resectable disease, with survival of 11-18 months. The survival rate for the first year is low, around 11-2 8% and less than 6% survive at 5 years. The purpose of the treatment is palliative to achieve improvements in symptomatology and the quality of life of the patients and extend their survival. Three types, infiltrating ductal adenocarcinoma, carcinoma of acinar cells and pancreatoblastoma are described (mainly in children). Adenocarcinoma is the most frequent subtype (> 90%).
dc.language.isocat
dc.publisherServei Català de la Salut
dc.relation.ispartofPrograma d'harmonització farmacoteràpeutica, Servei Català de la Salut
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPàncrees - Càncer - Tractament
dc.subjectMetàstasi
dc.subjectAlbúmina - Ús teràpeutic - Assaigs clínics
dc.subject.meshPancreatic Neoplasms
dc.subject.mesh/drug therapy
dc.subject.meshAlbumins
dc.subject.meshDrug Evaluation
dc.titlePaclitaxel unit a l'albúmina: tractament de primera línia del càncer de pàncrees metastàtic
dc.typeinfo:eu-repo/semantics/report
dc.subject.decsneoplasias pancreáticas
dc.subject.decs/tratamiento farmacológico
dc.subject.decsalbúminas
dc.subject.decsevaluación de medicamentos
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record